• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs

    Eye Test for Parkinson's Gains Breakthrough Designation

    Biomerics Forms New Business Unit

    J&J's New Monofocal IOL for Cataract Patients with Astigmatism

    FDA OKs MolecuLight's Handheld Fluorescence Imaging Device
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Cadence Inc.

    Pulse Systems

    Zeus

    Carclo Technical Plastics

    S-Y-M Products Company
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    Understanding Key Processes for Mixing APIs with Silicone

    How to Minimize Color Variations in Your Medical Device

    Don’t Touch: Gesture Tech Is Reshaping How We Interact with Devices

    Revenue-Based Financing: A New Form of Growth Capital

    Pre-Filled Safety Syringes and the Self-Administration Trend
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Carclo Technical Plastics

    Fusion Biotec Inc.

    RJG Inc.

    Marox Corporation

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Top30

    21. Smith & Nephew

    21. Smith & Nephew
    Related CONTENT
    • Mauna Kea Technologies Appoints Chief Operating Officer
    • Hologic Completes Acquisition of Cynosure
    • Global Endoscopy Devices Market to Reach $40.8 Billion by 2022
    • William F. Gearhart Appointed CEO at Raumedic Inc. in the U.S.
    • Defibtech Selects New CEO
    07.26.17
    $4.7 Billion

    KEY EXECUTIVES:
    Roberto Quarta, Chairman
    Olivier Bohuon, CEO
    Graham Baker, CFO
    Michael Frazzette, Chief Commercial Officer
    Rodrigo Bianchi, President, Asia Pacific and Emerging Markets
    Brad Cannon, President, Europe and Canada
    Glenn Warner, President, U.S.

    NUMBER OF EMPLOYEES: 15,644

    GLOBAL HEADQUARTERS: London, United Kingdom

    Few announcements shake up a corporation more than the sudden illness of its leader. At the start of February 2016, Smith & Nephew plc released the type of news nobody wants to hear: the company’s CEO, Olivier Bohuon, had been diagnosed with cancer. The press release revealing this development made sure to mollify readers by stating he was afflicted with “a highly treatable form of cancer,” but emotions were surely running high both within and outside the company as many pondered how Bohuon’s treatment would fare, and what management changes may occur in the near future.

    “Olivier will remain chief executive officer and be actively involved in running the company through much of his treatment period, which will begin later this month,” the release went on, somewhat satiating the worrisome masses. According to Smith & Nephew, the only governance measure taken during Bohuon’s treatment was calling upon Chairman Roberto Quarta’s executive oversight, if required. “The treatment will include chemotherapy, and is expected to be completed by late autumn,” the release assured readers.

    News regarding Bohuon’s treatment and recovery was scarce, save for whatever hints about his health could be gleaned from his voice in earnings calls every quarter. Thankfully, Quarta’s statement in Smith & Nephew’s FY 2016 (ended Dec. 31) report brought happy tidings.

    “In early 2016 we announced that our chief executive officer, Olivier Bohuon, had been diagnosed with cancer, and would require treatment across much of the year,” he explained. “We were delighted to welcome him back to work full time in October.”

    “As you know I undertook medical treatment during 2016 and I want to thank shareholders and employees who sent me their best wishes during this time,” Bohuon said at the end of his letter in the company’s annual report. “Moreover, I want to thank all of our employees who continue to strive to deliver on our commitments, embodying a Smith & Nephew culture immersed in our values of innovation, trust, and performance. It is good to be back at work full-time amongst such inspiring people.”

    The sentiment is surely returned, Mr. Bohuon. Congratulations on the successful recovery!


    ANALYST INSIGHTS: As a key player in orthopedics and related minimally invasive surgery, Smith & Nephew is under pressure to perform. “Bolt-on” M&A has only had minor impacts while pricing pressure is hurting the company’s financial performance—leading to investors to freeze the pay of CEO Oliver Bohuon in March. This may lead to some more dramatic M&A movement in the near future.

    —Dave Sheppard, Co-Founder and Principal, MedWorld Advisors



    Revenues Remain Relatively Flat
    Smith & Nephew did achieve revenue growth in FY16 with $4.7 billion in sales, but the $35 million increase from 2015 is a far cry from the year-over-year $200 million growth the company had been achieving in 2014 and prior. The largest hindrance to the company’s growth was cited by both chairman and CEO to be difficult trading conditions in the Gulf States and China. According to Bohuon, the market conditions in those areas alone lopped off over a percentage point from the year.

    The company’s Sports Medicine, Trauma & Other franchise (which contains product lines for sports medicine joint repair, arthroscopic enabling technologies, trauma & extremities, and other surgical businesses) reported an increase of 1 percent from 2015 with $1.9 billion in sales. The most significant fuel for this growth came from the sports medicine joint repair portfolio, which includes a broad array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, including the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. This division rose 7 percent in global sales to $587 million from the prior year, with double digit growth in the United States thanks to gains made from the 2014 ArthroCare acquisition.

    Further broadening this division, in January 2016 Smith & Nephew acquired BST-CarGel, a first-line cartilage repair product that is used in tandem with microfracture and other bone marrow stimulation techniques for the initial treatment of most sizes of focal cartilage tears. BST-Cargel is a biopolymer-based solution mixed with a patient’s blood and implanted into the joint after a microfracture procedure. Delivered arthroscopically, it can treat damaged cartilage in synovial joints like the knee, hip, ankle, and shoulder. After implantation it functions as a scaffold, sticking to the cartilage surface to stabilize the blood clot while new cartilage is regenerated.

    The arthroscopic enabling technologies business, which contains an array of minimally invasive surgery-enabling systems and devices, was flat in 2016, earning $631 million. Further diversifying the company’s offerings in this division, Smith & Nephew also launched the Werewolf Coblation System in 2016. The Coblation process creates and applies an energy field called “glow discharge plasma” to ablate molecules in the tissue, and operates at lower temperatures than other radio frequency-based technologies. Werewolf beefs up the technology with a new controller to support a broad variety of wands, and also adds a range of advanced safety features. The Trauma & Extremities division, which features technologies that stabilize severe fractures, correct bone deformities, treat arthritis, and heal soft tissue complications, fell 4 percent to $475 million from the previous year due to destocking in the China business as well as reduced tender activity in the Gulf States.

    The Other Surgical Businesses franchise rose 5 percent from the previous year, exhibiting $214 million in sales. This section of the company undoubtedly faced the most changes of all in 2016, divesting one business and acquiring another.

    The company closed the book on its acquisition of surgical robotics company Blue Belt Technologies Inc. in January 2016. Blue Belt’s Navio surgical system provides robotics assistance in partial knee replacement surgery through CT-free navigation software and a hand-held, bone-shaping device. One of Smith & Nephew’s goals in acquiring Navio was to expand into total knee, cruciate retaining knee, and revision knee implants—and thus far the company was able to accomplish one of those goals. The company’s Journey II BCS and CR total knee systems were implanted with assistance from Navio for the first time in July 2016, allowing precise and efficient placement without a pre-operative CT scan. Currently available for the Journey II total knee system, additional total knee systems are expected to be supported by the Navio system in future releases.

    In August 2016, the company completed the sale of its Gynaecology business to Medtronic plc for $350 million. The business was built around Smith & Nephew’s resection technologies, mainly its Truclear System for hysteroscopic resection and removal of uterine tissue. The division had historically contributed a little over 1 percent to the company’s revenue, but is expected to strongly complement Medtronic’s existing portfolio.

    In October 2016, the company also christened a $55 million manufacturing plant devoted to sports medicine orthopedic devices. Stationed in Coyol Free Zone, Alajuela, Costa Rica, the facility will add up to 250 new job positions to the 1,700 existing ones, employing a total of 1,950 employees in Costa Rica.

    The Advanced Wound Management franchise, which encompasses products for wound care, bioactives, and devices, dropped 3 percent in 2016, garnering $1.2 billion in sales. The Advanced Wound Care portfolio (which includes offerings for exudate management, infection management, and a cornerstone range of products) was the largest contributor to this loss, falling 5 percent to $719 million in revenue due to destocking in China and weakness in sections of the European market that the strong U.S. performance could not offset. The Advanced Wound Bioactives division also experienced a 1 percent loss.

    The Advanced Wound Devices business is comprised of the company’s Negative Pressure Wound Therapy (NPWT) and surgical debridement product lines. It exhibited the only reported gain in this franchise, rising 3 percent from 2015 with $172 million in revenue. The Pico system, the company’s pioneering single-use, canister-free NPWT solution, led the charge in this division’s strong performance. In 2016, Pico was used for the millionth time to treat a patient. Designed for both open wounds and closed incisions and leveraging Smith & Nephew’s dressing technology, it’s as easy to apply as a wound dressing and provides a discreet, unobtrusive means to carry on NPWT in daily life.

    The Reconstruction franchise, which contains the company’s knee and hip implants, grew 3 percent to $1.5 billion in sales. Knee implants were the single largest revenue producer for the company, capturing 20 percent of total sales and rising 6 percent to $932 million from the previous year. The 2016 launch of the Anthem Total Knee System was one aspect driving growth here. Anthem’s launch caters to the growing trend of personalized orthopedic devices, designed from both intraoperative measurements and patient CT analysis to create a knee offering fit for a wide variety of patients. The limited market release of the Journey II XR bi-cruciate retaining knee implant and gains from the company’s 2015 purchase of the Zimmer Unicompartmental High Flex Knee for the U.S. market also fueled growth in this sector. The Blue Belt Technologies acquisition also began to add to the gain, as in July 2016 the Navio system was used for its first-ever robotics-assisted total knee replacement. Because less than 10 percent of knee replacements are partial (according to the company), moving Navio into total knee procedures stands to greatly increase the system’s utilization and grow this sector.

    The Hip Implants division fell 1 percent from 2015 with $597 million of revenue. The franchise offers a range of specialist products for hip joint reconstruction, including the Anthology and Synergy Hip Systems, the Polarstem Femoral Hip System, the R3 Acetabular System, and the Polarcup dual mobility system. According to the company, every year more than 2 million patients worldwide undergo total, resurfacing, and revision hip replacement procedures.

    During the 2016 American Academy of Orthopaedic Surgeons annual meeting, Smith & Nephew unveiled an intriguing addition to its hip portfolio—the Redapt Revision Acetabular Fully Porous Cup with Conceloc technology, which was cleared by the U.S. Food and Drug Administration in November 2015. Meant for revision cases where compromised bone makes implant fixation and stability more challenging, Redapt is additively manufactured to create an entirely porous implant to mimic the structure of cancellous bone and facilitate ingrowth.

    Redapt’s Conceloc Advanced Porous Titanium technology replaces external coatings—for example, sintered beads or fiber mesh—to promote osseointegration. Variable Angle Locking Screws also work within the implant’s geometry to provide both compression and a rigid construct to the acetabular shell.

    “This fully porous cup gives surgeons flexibility in ways that simply weren’t possible before,” Craig Della Valle, M.D., professor of orthopedic surgery at Rush University Medical Center in Chicago, who participated on the surgeon design team for the new Redapt Cup, said in a company press release. “The locking screws, screw-in trials, purpose-built liners, and screw hole patterns optimized for hard-to-access areas really set it apart during a revision procedure. This cup builds on good technology and turns it into something spectacular.”
    Related Searches
    • trauma
    • minimally invasive surgery
    • acquisition
    • ct
    Suggested For You
    5. Becton, Dickinson and Company 5. Becton, Dickinson and Company
    8. Stryker Corp. 8. Stryker Corp.
    9. Baxter International 9. Baxter International
    10. Abbott Laboratories 10. Abbott Laboratories
    25. Getinge Group 25. Getinge Group
    Entellus Medical to Acquire Spirox Entellus Medical to Acquire Spirox
    HeartFlow Names Executive Vice President and Chief Commercial Officer HeartFlow Names Executive Vice President and Chief Commercial Officer
    PerkinElmer to Acquire German Diagnostics Firm for $1.3 Billion PerkinElmer to Acquire German Diagnostics Firm for $1.3 Billion
    Tekni-Plex Invests $15 Million into new Chinese Facility Tekni-Plex Invests $15 Million into new Chinese Facility
    Baxter and Mayo Clinic Launch R&D Collaboration Baxter and Mayo Clinic Launch R&D Collaboration
    EnteroMedics Acquires the Gastric Vest System EnteroMedics Acquires the Gastric Vest System
    Biotheranostics Appoints New CEO Biotheranostics Appoints New CEO
    BD to Acquire Bard for $24 Billion BD to Acquire Bard for $24 Billion
    Defibtech Selects New CEO Defibtech Selects New CEO
    William F. Gearhart Appointed CEO at Raumedic Inc. in the U.S. William F. Gearhart Appointed CEO at Raumedic Inc. in the U.S.

    Related Top30

    • The 2019 Top 30 Global Medical Device Companies

      The 2019 Top 30 Global Medical Device Companies

      The lack of a significant megamerger in 2018 stood out in an industry that had become accustomed to annual blockbuster deals. There were enough small- to mid-sized deals to keep analysts interested, but the largest deal of last year—Boston Scie…
      Sean Fenske, Michael Barbella, & Sam Brusco, MPO Editorial Staff 07.30.19

    • 1. Medtronic

      1. Medtronic

      AT A GLANCE Rank: #1 (Last year: #1) $30.56 Billion Prior Fiscal: $29.95 Billion Percentage Change: +2.0% No. of Employees: 90,017 Global Headquarters: Dublin, Ireland KEY EXECUTIVES Omar Ishrak, Chairman and CEO Karen L. Parkhill, E…
      07.30.19

    • 2. Johnson & Johnson

      2. Johnson & Johnson

      AT A GLANCE Rank: #2 (Last year: #2) $26.99 Billion ($81.6B total) Prior Fiscal: $26.59 Billion Percentage Change: +1.5% No. of Employees: 135,100 (total) Global Headquarters: New Brunswick, N.J. KEY EXECUTIVES Alex Gorsky, Chairm…
      07.30.19


    • 3. GE Healthcare

      3. GE Healthcare

      AT A GLANCE Rank: #3 (Last year: #3) $19.78 Billion ($122B total) Prior Fiscal: $19.02 Billion Percentage Change: +4% No. of Employees: 53,800 (283,000 total) Global Headquarters: Chicago, Ill. KEY EXECUTIVES H. Lawrence Culp, Jr.…
      07.30.19

    • 4. Abbott

      4. Abbott

      AT A GLANCE Rank: #4 (Last year: #6) $18.93 Billion ($30.6B total) Prior Fiscal: $16.2 Billion Percentage Change: +17% No. of Employees: 103,000 Global Headquarters: Abbott Park, Ill. KEY EXECUTIVES Miles D. White, Chairman and CEO Ro…
      07.30.19

    • 5. Philips

      5. Philips

      AT A GLANCE Rank: #5 (Last year: #4) $16.09 Billion ($20.7B total) Prior Fiscal: $16.30 Billion Percentage Change: -1.2% No. of Employees: 77,400 (total) Global Headquarters: Amsterdam, The Netherlands KEY EXECUTIVES Frans van Houten, CEO…
      07.30.19


    • 6. BD

      6. BD

      AT A GLANCE Rank: #6 (Last year: #9) $15.98 Billion Prior Fiscal: $12.10 Billion Percentage Change: +32.1% No. of Employees: 76,032 Global Headquarters: Franklin Lakes, N.J. KEY EXECUTIVES Vincent A. Forlenza, Chairman and CEO Christopher R. Re…
      07.30.19

    • 7. Cardinal Health

      7. Cardinal Health

      AT A GLANCE Rank: #7 (Last year: #7) $15.58 Billion ($136.8B total) Prior Fiscal: $13.52 Billion Percentage Change: +15.0% No. of Employees: 50,200 (total) Global Headquarters: Dublin, Ohio KEY EXECUTIVES Gregory B. Kenny, Independent Boar…
      07.30.19

    • 7. Siemens Healthineers

      7. Siemens Healthineers

      AT A GLANCE Rank: #7 (Last year: #4) $15.58 Billion Prior Fiscal: $15.9 Billion Percentage Change: -2% No. of Employees: 50,000 Global Headquarters: Erlangen, Germany KEY EXECUTIVES Michael Sen, Chairman Dr. Bernd Montag, CEO Dr. Joc…
      07.30.19


    • 9. Stryker

      9. Stryker

      AT A GLANCE Rank: #9 (Last year: #8) $13.60 Billion Prior Fiscal: $12.44 Billion Percentage Change: +9.3% No. of Employees: 36,000 Global Headquarters: Kalamazoo, Mich. KEY EXECUTIVES Kevin A. Lobo, Chairman and CEO Glenn S. Boehnlein, VP and C…
      07.30.19

    • 10. Baxter

      10. Baxter

      AT A GLANCE Rank: #10 (Last year: #10) $11.12 Billion Prior Fiscal: $10.56 Billion Percentage Change: +5.3% No. of Employees: 50,000 Global Headquarters: Deerfield, Ill. KEY EXECUTIVES José (Joe) E. Almeida, Chairman, President, and CEO…
      07.30.19

    • 11. Boston Scientific

      11. Boston Scientific

      AT A GLANCE Rank: #11 (Last year: #11) $9.82 Billion Prior Fiscal: $9.0 Billion Percentage Change: +8% No. of Employees: 32,000 Global Headquarters: Marlborough, Mass. KEY EXECUTIVES Mike Mahoney, Chairman and CEO Daniel J. Brennan, E…
      07.30.19

    • 12. Danaher

      12. Danaher

      AT A GLANCE Rank: #12 (Last year: #13) $9.10 Billion ($19.9B total) Prior Fiscal: $8.60 Billion Percentage Change: +5.81% No. of Employees: 71,000 (total) Global Headquarters: Washington, D.C. KEY EXECUTIVES Thomas P. Joyce Jr., P…
      07.30.19

    • 13. EssilorLuxottica

      13. EssilorLuxottica

      AT A GLANCE Rank: #13 (Last year: #11) $8.53 Billion ($18.5B total) Prior Fiscal: $8.46 Billion Percentage Change: +0.8% No. of Employees: 150,000 (total) Global Headquarters: Charenton-le-Pont, France KEY EXECUTIVES Leonardo Del…
      07.30.19

    • 14. Zimmer Biomet

      14. Zimmer Biomet

      AT A GLANCE Rank: #14 (Last year: #15) $7.93 Billion Prior Fiscal: $7.80 billion Percentage Change: +1.7% No. of Employees: 19,000 Global Headquarters: Warsaw, Ind. KEY EXECUTIVES Bryan C. Hanson, President and CEO Suketu Upadhyay, Ex…
      07.30.19


    Breaking News
    • Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    • Eye Test for Parkinson's Gains Breakthrough Designation
    • Biomerics Forms New Business Unit
    • J&J's New Monofocal IOL for Cataract Patients with Astigmatism
    • FDA OKs MolecuLight's Handheld Fluorescence Imaging Device
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    International Scientific Society Calls for Omega-3 Blood Testing in Future Research
    Pharmactive Affron Saffron May Help Relieve Depression Symptoms
    Warmer Temperatures Could Lead to Concerning Levels of Arsenic in Rice
    Coatings World

    Latest Breaking News From Coatings World

    Michelman Makes United Way of Greater Cincinnati’s List of Top 25 Corporate Campaigns
    BCF: Coatings Industry Reports Record Improvement in Waste, Recycling, Accident Rates
    BASF Doubling Automotive Refinish Coatings Production Capacity at Jiangmen, China Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Philips & Paige to Deliver Clinical-Grade AI Applications to Pathology Labs
    Eye Test for Parkinson's Gains Breakthrough Designation
    Biomerics Forms New Business Unit
    Contract Pharma

    Latest Breaking News From Contract Pharma

    PhRMA Appoints Federal Advocacy SVP
    CStone Hires Shirley Zhao as GM
    Stevanato Group Begins Construction on TEC
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Pantone Names Classic Blue the 2020 Color of the Year
    Burst Launches Black Expanding Dental Floss
    Glossier Enters Nordstrom for the Holidays
    Happi

    Latest Breaking News From Happi

    Raining Rose Expands Exec Team
    Scott’s Sells Personal Care Production Site
    Givaudan Unveils RitualEssenz Brazil
    Ink World

    Latest Breaking News From Ink World

    Geoff Loftus Joins EFI
    Berlin Packaging Wins 2 WorldStar Awards
    Graphic Village Expands Offerings with Canon Solutions America
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Tags & Labels Printing adds Heidelberg’s Versafire EP
    Austrian converter installs first Nilpeter press
    Converters Expo schedules return to Green Bay, WI
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Thrace to Relocate U.S. Capacity
    FiltXPO Speaker Line-Up Announced
    Nölken Incorporates Sustainable Wipes Packaging
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Orthofix Appoints New Spine Business Leader
    Viant to Halt EtO Sterilization at Michigan Plant by End of Year
    Synaptive Medical's Modus V Expands Into Spine Market
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    IDTechEx Show! Announces Graphene Award Winner
    OE-A Continues to Bring Future of Printed Electronics to CES 2020
    Avancis, Smit Thermal, HZB, CNRS, Solliace Team for Higher Efficiencies in CIGS

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.